Business Description
Telix Pharmaceuticals is an Australian company that develops and sells specialized medicines that use radioactivity to detect and treat cancer. Founded in 2015 and headquartered in Melbourne, it has operations across Australia, North America, and Europe. Its product portfolio spans both treatment and diagnostic imaging, targeting cancers including prostate, kidney, brain, and bone, with several products already on the market and others currently in late-stage clinical trials. The company also provides manufacturing services and works with external research partners, such as University Hospital Essen, to advance its pipeline.
